4//SEC Filing
KENYON LAWRENCE A 4
Accession 0001209191-19-049497
CIK 0001649989other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:04 PM ET
Size
5.7 KB
Accession
0001209191-19-049497
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2019-09-12+450,000→ 450,000 totalExercise: $1.75Exp: 2029-09-12→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in four equal annual installments beginning on September 12, 2020 such that the option shall be vested in full on September 12, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of a change in control as defined in the Issuer's 2015 Equity Incentive Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001230484
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:04 PM ET
- Size
- 5.7 KB